Clinical trial
Asthma/Steroid Withdrawal Study
NCT00395239 · University of Alberta, Other · Terminated
Key facts
| NCT number | NCT00395239 |
|---|---|
| Title | Asthma/Steroid Withdrawal Study |
| Official title | The Temporal Sequence of Inflammatory Mediators During a Controlled Exacerbation of Asthma by Steroid Withdrawal. |
| Lead sponsor | University of Alberta, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | inhaled corticosteroid |
| Enrollment | 6 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2015 |
| Completion | Oct 1, 2015 |
| First posted | Nov 2, 2006 |
| Last update posted | May 26, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: